Aptamers - Global Market Outlook (2017-2023)
According to Stratistics MRC, the Global Aptamers market is expected to grow from $128.80 million in 2016 to reach $408.14 million by 2023 with a CAGR of 17.9%. Rising investments in R&D of biotechnology and pharmaceutical industries, technological advancements and high efficient and cost-reduced process for binding larger molecules as compared to antibodies are the some of the key factors propelling the market growth. However, lack of awareness about the technology in developing economies and inadequate regulatory structure are hampering the market. The increased applications of aptamers in the food and chemicals industries are expected to create huge opportunities for market growth.
By product, the DNA aptamers are expected to have huge potential in the diagnosis and treatment of human disorder. DNA aptamers are generally used for the diagnosis of infectious disorder, cancer and cardiovascular disorder. DNA aptamers are oligonucleotides that bind to a variety of targets, such as small molecules, oligosaccharides, peptides, proteins, and cells. They are generated by an evolutionary engineering method called SELEX, using an oligonucleotide library with a randomized sequence. Once DNA aptamer sequences are obtained by SELEX, the aptamers can be chemically synthesized on a large GMP scale, for diagnostic and therapeutic applications.
Geographically, North America holds the largest market shareduring the forecast period. Technological advancements, huge investments in R&D and developments in Aptamers are the major factors contributing to the growth of the market in this region.
Some of the key players in the Aptamers market are Aptamer Solutions Ltd, Somalogic, Inc., Vivonics, Inc, Aptus Biotech S.L, Base Pair Biotechnologies, Inc, Aptagen, LLC, Trilink Biotechnologies, Inc, Aptamer Sciences Inc, Neoventures Biotechnology Inc, Am Biotechnologies, LLC, NOXXON Pharma, Ophthotech Corporation, Novartis AG, NeoNeuro SAS and Apta Targets.
Applications Covered:
By product, the DNA aptamers are expected to have huge potential in the diagnosis and treatment of human disorder. DNA aptamers are generally used for the diagnosis of infectious disorder, cancer and cardiovascular disorder. DNA aptamers are oligonucleotides that bind to a variety of targets, such as small molecules, oligosaccharides, peptides, proteins, and cells. They are generated by an evolutionary engineering method called SELEX, using an oligonucleotide library with a randomized sequence. Once DNA aptamer sequences are obtained by SELEX, the aptamers can be chemically synthesized on a large GMP scale, for diagnostic and therapeutic applications.
Geographically, North America holds the largest market shareduring the forecast period. Technological advancements, huge investments in R&D and developments in Aptamers are the major factors contributing to the growth of the market in this region.
Some of the key players in the Aptamers market are Aptamer Solutions Ltd, Somalogic, Inc., Vivonics, Inc, Aptus Biotech S.L, Base Pair Biotechnologies, Inc, Aptagen, LLC, Trilink Biotechnologies, Inc, Aptamer Sciences Inc, Neoventures Biotechnology Inc, Am Biotechnologies, LLC, NOXXON Pharma, Ophthotech Corporation, Novartis AG, NeoNeuro SAS and Apta Targets.
Applications Covered:
- Research and Development
- Forensics
- Cancer
- Diagnostics
- Therapeutics Development
- Biodefense
- Other Applications
- Contract Research Organizations
- Academic and Government Research Institutes
- Biotechnology and Pharmaceutical Companies
- Other End Users
- Peptide Aptamers
- Nucleic Acid Aptamers
- SELEX
- Other Technologies
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends.
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
1 EXECUTIVE SUMMARY
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Technology Analysis
3.9 Emerging Markets
3.10 Futuristic Market Scenario
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL APTAMERS MARKET, BY APPLICATION
5.1 Introduction
5.2 Research and Development
5.2.1 Targeted Drug Delivery
5.2.2 Drug Discovery and Development
5.3 Forensics
5.4 Cancer
5.5 Diagnostics
5.5.1 Molecular Imaging
5.5.2 Biomarker Detection and Discovery
5.6 Therapeutics Development
5.7 Biodefense
5.8 Other Applications
5.8.1 Food Safety
5.8.2 Biosensors
6 GLOBAL APTAMERS MARKET, BY END USER
6.1 Introduction
6.2 Contract Research Organizations
6.3 Academic and Government Research Institutes
6.4 Biotechnology and Pharmaceutical Companies
6.5 Other End Users
7 GLOBAL APTAMERS MARKET, BY APTAMERS TYPE
7.1 Introduction
7.2 Peptide Aptamers
7.3 Nucleic Acid Aptamers
7.3.1 RNA-Based Aptamers
7.3.2 XNA-Based Aptamers
7.3.3 DNA-Based Aptamers
8 GLOBAL APTAMERS MARKET, BY TECHNOLOGY
8.1 Introduction
8.2 SELEX
8.3 Other Technologies
9 GLOBAL APTAMERS MARKET, BY GEOGRAPHY
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 KEY DEVELOPMENTS
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 COMPANY PROFILING
11.1 Aptamer Solutions Ltd.
11.2 Somalogic, Inc.
11.3 Vivonics, Inc.
11.4 Aptus Biotech S.L.
11.5 Base Pair Biotechnologies, Inc.
11.6 Aptagen, LLC
11.7 Trilink Biotechnologies, Inc.
11.8 Aptamer Sciences Inc.
11.9 Neoventures Biotechnology Inc.
11.10 Am Biotechnologies, LLC
11.11 NOXXON Pharma
11.12 Ophthotech Corporation
11.13 Novartis AG
11.14 NeoNeuro SAS
11.15 Optech Biotech
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Technology Analysis
3.9 Emerging Markets
3.10 Futuristic Market Scenario
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL APTAMERS MARKET, BY APPLICATION
5.1 Introduction
5.2 Research and Development
5.2.1 Targeted Drug Delivery
5.2.2 Drug Discovery and Development
5.3 Forensics
5.4 Cancer
5.5 Diagnostics
5.5.1 Molecular Imaging
5.5.2 Biomarker Detection and Discovery
5.6 Therapeutics Development
5.7 Biodefense
5.8 Other Applications
5.8.1 Food Safety
5.8.2 Biosensors
6 GLOBAL APTAMERS MARKET, BY END USER
6.1 Introduction
6.2 Contract Research Organizations
6.3 Academic and Government Research Institutes
6.4 Biotechnology and Pharmaceutical Companies
6.5 Other End Users
7 GLOBAL APTAMERS MARKET, BY APTAMERS TYPE
7.1 Introduction
7.2 Peptide Aptamers
7.3 Nucleic Acid Aptamers
7.3.1 RNA-Based Aptamers
7.3.2 XNA-Based Aptamers
7.3.3 DNA-Based Aptamers
8 GLOBAL APTAMERS MARKET, BY TECHNOLOGY
8.1 Introduction
8.2 SELEX
8.3 Other Technologies
9 GLOBAL APTAMERS MARKET, BY GEOGRAPHY
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 KEY DEVELOPMENTS
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 COMPANY PROFILING
11.1 Aptamer Solutions Ltd.
11.2 Somalogic, Inc.
11.3 Vivonics, Inc.
11.4 Aptus Biotech S.L.
11.5 Base Pair Biotechnologies, Inc.
11.6 Aptagen, LLC
11.7 Trilink Biotechnologies, Inc.
11.8 Aptamer Sciences Inc.
11.9 Neoventures Biotechnology Inc.
11.10 Am Biotechnologies, LLC
11.11 NOXXON Pharma
11.12 Ophthotech Corporation
11.13 Novartis AG
11.14 NeoNeuro SAS
11.15 Optech Biotech
LIST OF TABLES
Table 1 Global Aptamers Market Outlook, By Region (2015-2023) (US $MN)
Table 2 Global Aptamers Market Outlook, By Application (2015-2023) (US $MN)
Table 3 Global Aptamers Market Outlook, By Research and Development (2015-2023) (US $MN)
Table 4 Global Aptamers Market Outlook, By Targeted Drug Delivery (2015-2023) (US $MN)
Table 5 Global Aptamers Market Outlook, By Drug Discovery and Development (2015-2023) (US $MN)
Table 6 Global Aptamers Market Outlook, By Forensics (2015-2023) (US $MN)
Table 7 Global Aptamers Market Outlook, By Cancer (2015-2023) (US $MN)
Table 8 Global Aptamers Market Outlook, By Diagnostics (2015-2023) (US $MN)
Table 9 Global Aptamers Market Outlook, By Molecular Imaging (2015-2023) (US $MN)
Table 10 Global Aptamers Market Outlook, By Biomarker Detection and Discovery (2015-2023) (US $MN)
Table 11 Global Aptamers Market Outlook, By Therapeutics Development (2015-2023) (US $MN)
Table 12 Global Aptamers Market Outlook, By Biodefense (2015-2023) (US $MN)
Table 13 Global Aptamers Market Outlook, By Other Applications (2015-2023) (US $MN)
Table 14 Global Aptamers Market Outlook, By Food Safety (2015-2023) (US $MN)
Table 15 Global Aptamers Market Outlook, By Biosensors (2015-2023) (US $MN)
Table 16 Global Aptamers Market Outlook, By End User (2015-2023) (US $MN)
Table 17 Global Aptamers Market Outlook, By Contract Research Organizations (2015-2023) (US $MN)
Table 18 Global Aptamers Market Outlook, By Academic and Government Research Institutes (2015-2023) (US $MN)
Table 19 Global Aptamers Market Outlook, By Biotechnology and Pharmaceutical Companies (2015-2023) (US $MN)
Table 20 Global Aptamers Market Outlook, By Other End Users (2015-2023) (US $MN)
Table 21 Global Aptamers Market Outlook, By Aptamers Type (2015-2023) (US $MN)
Table 22 Global Aptamers Market Outlook, By Peptide Aptamers (2015-2023) (US $MN)
Table 23 Global Aptamers Market Outlook, By Nucleic Acid Aptamers (2015-2023) (US $MN)
Table 24 Global Aptamers Market Outlook, By RNA-Based Aptamers (2015-2023) (US $MN)
Table 25 Global Aptamers Market Outlook, By XNA-Based Aptamers (2015-2023) (US $MN)
Table 26 Global Aptamers Market Outlook, By DNA-Based Aptamers (2015-2023) (US $MN)
Table 27 Global Aptamers Market Outlook, By Technology (2015-2023) (US $MN)
Table 28 Global Aptamers Market Outlook, By SELEX (2015-2023) (US $MN)
Table 29 Global Aptamers Market Outlook, By Other Technologies (2015-2023) (US $MN)
Table 30 North America Aptamers Market Outlook, By Country (2015-2023) (US $MN)
Table 31 North America Aptamers Market Outlook, By Application (2015-2023) (US $MN)
Table 32 North America Aptamers Market Outlook, By Research and Development (2015-2023) (US $MN)
Table 33 North America Aptamers Market Outlook, By Targeted Drug Delivery (2015-2023) (US $MN)
Table 34 North America Aptamers Market Outlook, By Drug Discovery and Development (2015-2023) (US $MN)
Table 35 North America Aptamers Market Outlook, By Forensics (2015-2023) (US $MN)
Table 36 North America Aptamers Market Outlook, By Cancer (2015-2023) (US $MN)
Table 37 North America Aptamers Market Outlook, By Diagnostics (2015-2023) (US $MN)
Table 38 North America Aptamers Market Outlook, By Molecular Imaging (2015-2023) (US $MN)
Table 39 North America Aptamers Market Outlook, By Biomarker Detection and Discovery (2015-2023) (US $MN)
Table 40 North America Aptamers Market Outlook, By Therapeutics Development (2015-2023) (US $MN)
Table 41 North America Aptamers Market Outlook, By Biodefense (2015-2023) (US $MN)
Table 42 North America Aptamers Market Outlook, By Other Applications (2015-2023) (US $MN)
Table 43 North America Aptamers Market Outlook, By Food Safety (2015-2023) (US $MN)
Table 44 North America Aptamers Market Outlook, By Biosensors (2015-2023) (US $MN)
Table 45 North America Aptamers Market Outlook, By End User (2015-2023) (US $MN)
Table 46 North America Aptamers Market Outlook, By Contract Research Organizations (2015-2023) (US $MN)
Table 47 North America Aptamers Market Outlook, By Academic and Government Research Institutes (2015-2023) (US $MN)
Table 48 North America Aptamers Market Outlook, By Biotechnology and Pharmaceutical Companies (2015-2023) (US $MN)
Table 49 North America Aptamers Market Outlook, By Other End Users (2015-2023) (US $MN)
Table 50 North America Aptamers Market Outlook, By Aptamers Type (2015-2023) (US $MN)
Table 51 North America Aptamers Market Outlook, By Peptide Aptamers (2015-2023) (US $MN)
Table 52 North America Aptamers Market Outlook, By Nucleic Acid Aptamers (2015-2023) (US $MN)
Table 53 North America Aptamers Market Outlook, By RNA-Based Aptamers (2015-2023) (US $MN)
Table 54 North America Aptamers Market Outlook, By XNA-Based Aptamers (2015-2023) (US $MN)
Table 55 North America Aptamers Market Outlook, By DNA-Based Aptamers (2015-2023) (US $MN)
Table 56 North America Aptamers Market Outlook, By Technology (2015-2023) (US $MN)
Table 57 North America Aptamers Market Outlook, By SELEX (2015-2023) (US $MN)
Table 58 North America Aptamers Market Outlook, By Other Technologies (2015-2023) (US $MN)
Table 59 Europe Aptamers Market Outlook, By Country (2015-2023) (US $MN)
Table 60 Europe Aptamers Market Outlook, By Application (2015-2023) (US $MN)
Table 61 Europe Aptamers Market Outlook, By Research and Development (2015-2023) (US $MN)
Table 62 Europe Aptamers Market Outlook, By Targeted Drug Delivery (2015-2023) (US $MN)
Table 63 Europe Aptamers Market Outlook, By Drug Discovery and Development (2015-2023) (US $MN)
Table 64 Europe Aptamers Market Outlook, By Forensics (2015-2023) (US $MN)
Table 65 Europe Aptamers Market Outlook, By Cancer (2015-2023) (US $MN)
Table 66 Europe Aptamers Market Outlook, By Diagnostics (2015-2023) (US $MN)
Table 67 Europe Aptamers Market Outlook, By Molecular Imaging (2015-2023) (US $MN)
Table 68 Europe Aptamers Market Outlook, By Biomarker Detection and Discovery (2015-2023) (US $MN)
Table 69 Europe Aptamers Market Outlook, By Therapeutics Development (2015-2023) (US $MN)
Table 70 Europe Aptamers Market Outlook, By Biodefense (2015-2023) (US $MN)
Table 71 Europe Aptamers Market Outlook, By Other Applications (2015-2023) (US $MN)
Table 72 Europe Aptamers Market Outlook, By Food Safety (2015-2023) (US $MN)
Table 73 Europe Aptamers Market Outlook, By Biosensors (2015-2023) (US $MN)
Table 74 Europe Aptamers Market Outlook, By End User (2015-2023) (US $MN)
Table 75 Europe Aptamers Market Outlook, By Contract Research Organizations (2015-2023) (US $MN)
Table 76 Europe Aptamers Market Outlook, By Academic and Government Research Institutes (2015-2023) (US $MN)
Table 77 Europe Aptamers Market Outlook, By Biotechnology and Pharmaceutical Companies (2015-2023) (US $MN)
Table 78 Europe Aptamers Market Outlook, By Other End Users (2015-2023) (US $MN)
Table 79 Europe Aptamers Market Outlook, By Aptamers Type (2015-2023) (US $MN)
Table 80 Europe Aptamers Market Outlook, By Peptide Aptamers (2015-2023) (US $MN)
Table 81 Europe Aptamers Market Outlook, By Nucleic Acid Aptamers (2015-2023) (US $MN)
Table 82 Europe Aptamers Market Outlook, By RNA-Based Aptamers (2015-2023) (US $MN)
Table 83 Europe Aptamers Market Outlook, By XNA-Based Aptamers (2015-2023) (US $MN)
Table 84 Europe Aptamers Market Outlook, By DNA-Based Aptamers (2015-2023) (US $MN)
Table 85 Europe Aptamers Market Outlook, By Technology (2015-2023) (US $MN)
Table 86 Europe Aptamers Market Outlook, By SELEX (2015-2023) (US $MN)
Table 87 Europe Aptamers Market Outlook, By Other Technologies (2015-2023) (US $MN)
Table 88 Asia Pacific Aptamers Market Outlook, By Country (2015-2023) (US $MN)
Table 89 Asia Pacific Aptamers Market Outlook, By Application (2015-2023) (US $MN)
Table 90 Asia Pacific Aptamers Market Outlook, By Research and Development (2015-2023) (US $MN)
Table 91 Asia Pacific Aptamers Market Outlook, By Targeted Drug Delivery (2015-2023) (US $MN)
Table 92 Asia Pacific Aptamers Market Outlook, By Drug Discovery and Development (2015-2023) (US $MN)
Table 93 Asia Pacific Aptamers Market Outlook, By Forensics (2015-2023) (US $MN)
Table 94 Asia Pacific Aptamers Market Outlook, By Cancer (2015-2023) (US $MN)
Table 95 Asia Pacific Aptamers Market Outlook, By Diagnostics (2015-2023) (US $MN)
Table 96 Asia Pacific Aptamers Market Outlook, By Molecular Imaging (2015-2023) (US $MN)
Table 97 Asia Pacific Aptamers Market Outlook, By Biomarker Detection and Discovery (2015-2023) (US $MN)
Table 98 Asia Pacific Aptamers Market Outlook, By Therapeutics Development (2015-2023) (US $MN)
Table 99 Asia Pacific Aptamers Market Outlook, By Biodefense (2015-2023) (US $MN)
Table 100 Asia Pacific Aptamers Market Outlook, By Other Applications (2015-2023) (US $MN)
Table 101 Asia Pacific Aptamers Market Outlook, By Food Safety (2015-2023) (US $MN)
Table 102 Asia Pacific Aptamers Market Outlook, By Biosensors (2015-2023) (US $MN)
Table 103 Asia Pacific Aptamers Market Outlook, By End User (2015-2023) (US $MN)
Table 104 Asia Pacific Aptamers Market Outlook, By Contract Research Organizations (2015-2023) (US $MN)
Table 105 Asia Pacific Aptamers Market Outlook, By Academic and Government Research Institutes (2015-2023) (US $MN)
Table 106 Asia Pacific Aptamers Market Outlook, By Biotechnology and Pharmaceutical Companies (2015-2023) (US $MN)
Table 107 Asia Pacific Aptamers Market Outlook, By Other End Users (2015-2023) (US $MN)
Table 108 Asia Pacific Aptamers Market Outlook, By Aptamers Type (2015-2023) (US $MN)
Table 109 Asia Pacific Aptamers Market Outlook, By Peptide Aptamers (2015-2023) (US $MN)
Table 110 Asia Pacific Aptamers Market Outlook, By Nucleic Acid Aptamers (2015-2023) (US $MN)
Table 111 Asia Pacific Aptamers Market Outlook, By RNA-Based Aptamers (2015-2023) (US $MN)
Table 112 Asia Pacific Aptamers Market Outlook, By XNA-Based Aptamers (2015-2023) (US $MN)
Table 113 Asia Pacific Aptamers Market Outlook, By DNA-Based Aptamers (2015-2023) (US $MN)
Table 114 Asia Pacific Aptamers Market Outlook, By Technology (2015-2023) (US $MN)
Table 115 Asia Pacific Aptamers Market Outlook, By SELEX (2015-2023) (US $MN)
Table 116 Asia Pacific Aptamers Market Outlook, By Other Technologies (2015-2023) (US $MN)
Table 117 South America Aptamers Market Outlook, By Country (2015-2023) (US $MN)
Table 118 South America Aptamers Market Outlook, By Application (2015-2023) (US $MN)
Table 119 South America Aptamers Market Outlook, By Research and Development (2015-2023) (US $MN)
Table 120 South America Aptamers Market Outlook, By Targeted Drug Delivery (2015-2023) (US $MN)
Table 121 South America Aptamers Market Outlook, By Drug Discovery and Development (2015-2023) (US $MN)
Table 122 South America Aptamers Market Outlook, By Forensics (2015-2023) (US $MN)
Table 123 South America Aptamers Market Outlook, By Cancer (2015-2023) (US $MN)
Table 124 South America Aptamers Market Outlook, By Diagnostics (2015-2023) (US $MN)
Table 125 South America Aptamers Market Outlook, By Molecular Imaging (2015-2023) (US $MN)
Table 126 South America Aptamers Market Outlook, By Biomarker Detection and Discovery (2015-2023) (US $MN)
Table 127 South America Aptamers Market Outlook, By Therapeutics Development (2015-2023) (US $MN)
Table 128 South America Aptamers Market Outlook, By Biodefense (2015-2023) (US $MN)
Table 129 South America Aptamers Market Outlook, By Other Applications (2015-2023) (US $MN)
Table 130 South America Aptamers Market Outlook, By Food Safety (2015-2023) (US $MN)
Table 131 South America Aptamers Market Outlook, By Biosensors (2015-2023) (US $MN)
Table 132 South America Aptamers Market Outlook, By End User (2015-2023) (US $MN)
Table 133 South America Aptamers Market Outlook, By Contract Research Organizations (2015-2023) (US $MN)
Table 134 South America Aptamers Market Outlook, By Academic and Government Research Institutes (2015-2023) (US $MN)
Table 135 South America Aptamers Market Outlook, By Biotechnology and Pharmaceutical Companies (2015-2023) (US $MN)
Table 136 South America Aptamers Market Outlook, By Other End Users (2015-2023) (US $MN)
Table 137 South America Aptamers Market Outlook, By Aptamers Type (2015-2023) (US $MN)
Table 138 South America Aptamers Market Outlook, By Peptide Aptamers (2015-2023) (US $MN)
Table 139 South America Aptamers Market Outlook, By Nucleic Acid Aptamers (2015-2023) (US $MN)
Table 140 South America Aptamers Market Outlook, By RNA-Based Aptamers (2015-2023) (US $MN)
Table 141 South America Aptamers Market Outlook, By XNA-Based Aptamers (2015-2023) (US $MN)
Table 142 South America Aptamers Market Outlook, By DNA-Based Aptamers (2015-2023) (US $MN)
Table 143 South America Aptamers Market Outlook, By Technology (2015-2023) (US $MN)
Table 144 South America Aptamers Market Outlook, By SELEX (2015-2023) (US $MN)
Table 145 South America Aptamers Market Outlook, By Other Technologies (2015-2023) (US $MN)
Table 146 Middle East & Africa Aptamers Market Outlook, By Country (2015-2023) (US $MN)
Table 147 Middle East & Africa Aptamers Market Outlook, By Application (2015-2023) (US $MN)
Table 148 Middle East & Africa Aptamers Market Outlook, By Research and Development (2015-2023) (US $MN)
Table 149 Middle East & Africa Aptamers Market Outlook, By Targeted Drug Delivery (2015-2023) (US $MN)
Table 150 Middle East & Africa Aptamers Market Outlook, By Drug Discovery and Development (2015-2023) (US $MN)
Table 151 Middle East & Africa Aptamers Market Outlook, By Forensics (2015-2023) (US $MN)
Table 152 Middle East & Africa Aptamers Market Outlook, By Cancer (2015-2023) (US $MN)
Table 153 Middle East & Africa Aptamers Market Outlook, By Diagnostics (2015-2023) (US $MN)
Table 154 Middle East & Africa Aptamers Market Outlook, By Molecular Imaging (2015-2023) (US $MN)
Table 155 Middle East & Africa Aptamers Market Outlook, By Biomarker Detection and Discovery (2015-2023) (US $MN)
Table 156 Middle East & Africa Aptamers Market Outlook, By Therapeutics Development (2015-2023) (US $MN)
Table 157 Middle East & Africa Aptamers Market Outlook, By Biodefense (2015-2023) (US $MN)
Table 158 Middle East & Africa Aptamers Market Outlook, By Other Applications (2015-2023) (US $MN)
Table 159 Middle East & Africa Aptamers Market Outlook, By Food Safety (2015-2023) (US $MN)
Table 160 Middle East & Africa Aptamers Market Outlook, By Biosensors (2015-2023) (US $MN)
Table 161 Middle East & Africa Aptamers Market Outlook, By End User (2015-2023) (US $MN)
Table 162 Middle East & Africa Aptamers Market Outlook, By Contract Research Organizations (2015-2023) (US $MN)
Table 163 Middle East & Africa Aptamers Market Outlook, By Academic and Government Research Institutes (2015-2023) (US $MN)
Table 164 Middle East & Africa Aptamers Market Outlook, By Biotechnology and Pharmaceutical Companies (2015-2023) (US $MN)
Table 165 Middle East & Africa Aptamers Market Outlook, By Other End Users (2015-2023) (US $MN)
Table 166 Middle East & Africa Aptamers Market Outlook, By Aptamers Type (2015-2023) (US $MN)
Table 167 Middle East & Africa Aptamers Market Outlook, By Peptide Aptamers (2015-2023) (US $MN)
Table 168 Middle East & Africa Aptamers Market Outlook, By Nucleic Acid Aptamers (2015-2023) (US $MN)
Table 169 Middle East & Africa Aptamers Market Outlook, By RNA-Based Aptamers (2015-2023) (US $MN)
Table 170 Middle East & Africa Aptamers Market Outlook, By XNA-Based Aptamers (2015-2023) (US $MN)
Table 171 Middle East & Africa Aptamers Market Outlook, By DNA-Based Aptamers (2015-2023) (US $MN)
Table 172 Middle East & Africa Aptamers Market Outlook, By Technology (2015-2023) (US $MN)
Table 173 Middle East & Africa Aptamers Market Outlook, By SELEX (2015-2023) (US $MN)
Table 174 Middle East & Africa Aptamers Market Outlook, By Other Technologies (2015-2023) (US $MN)
Table 1 Global Aptamers Market Outlook, By Region (2015-2023) (US $MN)
Table 2 Global Aptamers Market Outlook, By Application (2015-2023) (US $MN)
Table 3 Global Aptamers Market Outlook, By Research and Development (2015-2023) (US $MN)
Table 4 Global Aptamers Market Outlook, By Targeted Drug Delivery (2015-2023) (US $MN)
Table 5 Global Aptamers Market Outlook, By Drug Discovery and Development (2015-2023) (US $MN)
Table 6 Global Aptamers Market Outlook, By Forensics (2015-2023) (US $MN)
Table 7 Global Aptamers Market Outlook, By Cancer (2015-2023) (US $MN)
Table 8 Global Aptamers Market Outlook, By Diagnostics (2015-2023) (US $MN)
Table 9 Global Aptamers Market Outlook, By Molecular Imaging (2015-2023) (US $MN)
Table 10 Global Aptamers Market Outlook, By Biomarker Detection and Discovery (2015-2023) (US $MN)
Table 11 Global Aptamers Market Outlook, By Therapeutics Development (2015-2023) (US $MN)
Table 12 Global Aptamers Market Outlook, By Biodefense (2015-2023) (US $MN)
Table 13 Global Aptamers Market Outlook, By Other Applications (2015-2023) (US $MN)
Table 14 Global Aptamers Market Outlook, By Food Safety (2015-2023) (US $MN)
Table 15 Global Aptamers Market Outlook, By Biosensors (2015-2023) (US $MN)
Table 16 Global Aptamers Market Outlook, By End User (2015-2023) (US $MN)
Table 17 Global Aptamers Market Outlook, By Contract Research Organizations (2015-2023) (US $MN)
Table 18 Global Aptamers Market Outlook, By Academic and Government Research Institutes (2015-2023) (US $MN)
Table 19 Global Aptamers Market Outlook, By Biotechnology and Pharmaceutical Companies (2015-2023) (US $MN)
Table 20 Global Aptamers Market Outlook, By Other End Users (2015-2023) (US $MN)
Table 21 Global Aptamers Market Outlook, By Aptamers Type (2015-2023) (US $MN)
Table 22 Global Aptamers Market Outlook, By Peptide Aptamers (2015-2023) (US $MN)
Table 23 Global Aptamers Market Outlook, By Nucleic Acid Aptamers (2015-2023) (US $MN)
Table 24 Global Aptamers Market Outlook, By RNA-Based Aptamers (2015-2023) (US $MN)
Table 25 Global Aptamers Market Outlook, By XNA-Based Aptamers (2015-2023) (US $MN)
Table 26 Global Aptamers Market Outlook, By DNA-Based Aptamers (2015-2023) (US $MN)
Table 27 Global Aptamers Market Outlook, By Technology (2015-2023) (US $MN)
Table 28 Global Aptamers Market Outlook, By SELEX (2015-2023) (US $MN)
Table 29 Global Aptamers Market Outlook, By Other Technologies (2015-2023) (US $MN)
Table 30 North America Aptamers Market Outlook, By Country (2015-2023) (US $MN)
Table 31 North America Aptamers Market Outlook, By Application (2015-2023) (US $MN)
Table 32 North America Aptamers Market Outlook, By Research and Development (2015-2023) (US $MN)
Table 33 North America Aptamers Market Outlook, By Targeted Drug Delivery (2015-2023) (US $MN)
Table 34 North America Aptamers Market Outlook, By Drug Discovery and Development (2015-2023) (US $MN)
Table 35 North America Aptamers Market Outlook, By Forensics (2015-2023) (US $MN)
Table 36 North America Aptamers Market Outlook, By Cancer (2015-2023) (US $MN)
Table 37 North America Aptamers Market Outlook, By Diagnostics (2015-2023) (US $MN)
Table 38 North America Aptamers Market Outlook, By Molecular Imaging (2015-2023) (US $MN)
Table 39 North America Aptamers Market Outlook, By Biomarker Detection and Discovery (2015-2023) (US $MN)
Table 40 North America Aptamers Market Outlook, By Therapeutics Development (2015-2023) (US $MN)
Table 41 North America Aptamers Market Outlook, By Biodefense (2015-2023) (US $MN)
Table 42 North America Aptamers Market Outlook, By Other Applications (2015-2023) (US $MN)
Table 43 North America Aptamers Market Outlook, By Food Safety (2015-2023) (US $MN)
Table 44 North America Aptamers Market Outlook, By Biosensors (2015-2023) (US $MN)
Table 45 North America Aptamers Market Outlook, By End User (2015-2023) (US $MN)
Table 46 North America Aptamers Market Outlook, By Contract Research Organizations (2015-2023) (US $MN)
Table 47 North America Aptamers Market Outlook, By Academic and Government Research Institutes (2015-2023) (US $MN)
Table 48 North America Aptamers Market Outlook, By Biotechnology and Pharmaceutical Companies (2015-2023) (US $MN)
Table 49 North America Aptamers Market Outlook, By Other End Users (2015-2023) (US $MN)
Table 50 North America Aptamers Market Outlook, By Aptamers Type (2015-2023) (US $MN)
Table 51 North America Aptamers Market Outlook, By Peptide Aptamers (2015-2023) (US $MN)
Table 52 North America Aptamers Market Outlook, By Nucleic Acid Aptamers (2015-2023) (US $MN)
Table 53 North America Aptamers Market Outlook, By RNA-Based Aptamers (2015-2023) (US $MN)
Table 54 North America Aptamers Market Outlook, By XNA-Based Aptamers (2015-2023) (US $MN)
Table 55 North America Aptamers Market Outlook, By DNA-Based Aptamers (2015-2023) (US $MN)
Table 56 North America Aptamers Market Outlook, By Technology (2015-2023) (US $MN)
Table 57 North America Aptamers Market Outlook, By SELEX (2015-2023) (US $MN)
Table 58 North America Aptamers Market Outlook, By Other Technologies (2015-2023) (US $MN)
Table 59 Europe Aptamers Market Outlook, By Country (2015-2023) (US $MN)
Table 60 Europe Aptamers Market Outlook, By Application (2015-2023) (US $MN)
Table 61 Europe Aptamers Market Outlook, By Research and Development (2015-2023) (US $MN)
Table 62 Europe Aptamers Market Outlook, By Targeted Drug Delivery (2015-2023) (US $MN)
Table 63 Europe Aptamers Market Outlook, By Drug Discovery and Development (2015-2023) (US $MN)
Table 64 Europe Aptamers Market Outlook, By Forensics (2015-2023) (US $MN)
Table 65 Europe Aptamers Market Outlook, By Cancer (2015-2023) (US $MN)
Table 66 Europe Aptamers Market Outlook, By Diagnostics (2015-2023) (US $MN)
Table 67 Europe Aptamers Market Outlook, By Molecular Imaging (2015-2023) (US $MN)
Table 68 Europe Aptamers Market Outlook, By Biomarker Detection and Discovery (2015-2023) (US $MN)
Table 69 Europe Aptamers Market Outlook, By Therapeutics Development (2015-2023) (US $MN)
Table 70 Europe Aptamers Market Outlook, By Biodefense (2015-2023) (US $MN)
Table 71 Europe Aptamers Market Outlook, By Other Applications (2015-2023) (US $MN)
Table 72 Europe Aptamers Market Outlook, By Food Safety (2015-2023) (US $MN)
Table 73 Europe Aptamers Market Outlook, By Biosensors (2015-2023) (US $MN)
Table 74 Europe Aptamers Market Outlook, By End User (2015-2023) (US $MN)
Table 75 Europe Aptamers Market Outlook, By Contract Research Organizations (2015-2023) (US $MN)
Table 76 Europe Aptamers Market Outlook, By Academic and Government Research Institutes (2015-2023) (US $MN)
Table 77 Europe Aptamers Market Outlook, By Biotechnology and Pharmaceutical Companies (2015-2023) (US $MN)
Table 78 Europe Aptamers Market Outlook, By Other End Users (2015-2023) (US $MN)
Table 79 Europe Aptamers Market Outlook, By Aptamers Type (2015-2023) (US $MN)
Table 80 Europe Aptamers Market Outlook, By Peptide Aptamers (2015-2023) (US $MN)
Table 81 Europe Aptamers Market Outlook, By Nucleic Acid Aptamers (2015-2023) (US $MN)
Table 82 Europe Aptamers Market Outlook, By RNA-Based Aptamers (2015-2023) (US $MN)
Table 83 Europe Aptamers Market Outlook, By XNA-Based Aptamers (2015-2023) (US $MN)
Table 84 Europe Aptamers Market Outlook, By DNA-Based Aptamers (2015-2023) (US $MN)
Table 85 Europe Aptamers Market Outlook, By Technology (2015-2023) (US $MN)
Table 86 Europe Aptamers Market Outlook, By SELEX (2015-2023) (US $MN)
Table 87 Europe Aptamers Market Outlook, By Other Technologies (2015-2023) (US $MN)
Table 88 Asia Pacific Aptamers Market Outlook, By Country (2015-2023) (US $MN)
Table 89 Asia Pacific Aptamers Market Outlook, By Application (2015-2023) (US $MN)
Table 90 Asia Pacific Aptamers Market Outlook, By Research and Development (2015-2023) (US $MN)
Table 91 Asia Pacific Aptamers Market Outlook, By Targeted Drug Delivery (2015-2023) (US $MN)
Table 92 Asia Pacific Aptamers Market Outlook, By Drug Discovery and Development (2015-2023) (US $MN)
Table 93 Asia Pacific Aptamers Market Outlook, By Forensics (2015-2023) (US $MN)
Table 94 Asia Pacific Aptamers Market Outlook, By Cancer (2015-2023) (US $MN)
Table 95 Asia Pacific Aptamers Market Outlook, By Diagnostics (2015-2023) (US $MN)
Table 96 Asia Pacific Aptamers Market Outlook, By Molecular Imaging (2015-2023) (US $MN)
Table 97 Asia Pacific Aptamers Market Outlook, By Biomarker Detection and Discovery (2015-2023) (US $MN)
Table 98 Asia Pacific Aptamers Market Outlook, By Therapeutics Development (2015-2023) (US $MN)
Table 99 Asia Pacific Aptamers Market Outlook, By Biodefense (2015-2023) (US $MN)
Table 100 Asia Pacific Aptamers Market Outlook, By Other Applications (2015-2023) (US $MN)
Table 101 Asia Pacific Aptamers Market Outlook, By Food Safety (2015-2023) (US $MN)
Table 102 Asia Pacific Aptamers Market Outlook, By Biosensors (2015-2023) (US $MN)
Table 103 Asia Pacific Aptamers Market Outlook, By End User (2015-2023) (US $MN)
Table 104 Asia Pacific Aptamers Market Outlook, By Contract Research Organizations (2015-2023) (US $MN)
Table 105 Asia Pacific Aptamers Market Outlook, By Academic and Government Research Institutes (2015-2023) (US $MN)
Table 106 Asia Pacific Aptamers Market Outlook, By Biotechnology and Pharmaceutical Companies (2015-2023) (US $MN)
Table 107 Asia Pacific Aptamers Market Outlook, By Other End Users (2015-2023) (US $MN)
Table 108 Asia Pacific Aptamers Market Outlook, By Aptamers Type (2015-2023) (US $MN)
Table 109 Asia Pacific Aptamers Market Outlook, By Peptide Aptamers (2015-2023) (US $MN)
Table 110 Asia Pacific Aptamers Market Outlook, By Nucleic Acid Aptamers (2015-2023) (US $MN)
Table 111 Asia Pacific Aptamers Market Outlook, By RNA-Based Aptamers (2015-2023) (US $MN)
Table 112 Asia Pacific Aptamers Market Outlook, By XNA-Based Aptamers (2015-2023) (US $MN)
Table 113 Asia Pacific Aptamers Market Outlook, By DNA-Based Aptamers (2015-2023) (US $MN)
Table 114 Asia Pacific Aptamers Market Outlook, By Technology (2015-2023) (US $MN)
Table 115 Asia Pacific Aptamers Market Outlook, By SELEX (2015-2023) (US $MN)
Table 116 Asia Pacific Aptamers Market Outlook, By Other Technologies (2015-2023) (US $MN)
Table 117 South America Aptamers Market Outlook, By Country (2015-2023) (US $MN)
Table 118 South America Aptamers Market Outlook, By Application (2015-2023) (US $MN)
Table 119 South America Aptamers Market Outlook, By Research and Development (2015-2023) (US $MN)
Table 120 South America Aptamers Market Outlook, By Targeted Drug Delivery (2015-2023) (US $MN)
Table 121 South America Aptamers Market Outlook, By Drug Discovery and Development (2015-2023) (US $MN)
Table 122 South America Aptamers Market Outlook, By Forensics (2015-2023) (US $MN)
Table 123 South America Aptamers Market Outlook, By Cancer (2015-2023) (US $MN)
Table 124 South America Aptamers Market Outlook, By Diagnostics (2015-2023) (US $MN)
Table 125 South America Aptamers Market Outlook, By Molecular Imaging (2015-2023) (US $MN)
Table 126 South America Aptamers Market Outlook, By Biomarker Detection and Discovery (2015-2023) (US $MN)
Table 127 South America Aptamers Market Outlook, By Therapeutics Development (2015-2023) (US $MN)
Table 128 South America Aptamers Market Outlook, By Biodefense (2015-2023) (US $MN)
Table 129 South America Aptamers Market Outlook, By Other Applications (2015-2023) (US $MN)
Table 130 South America Aptamers Market Outlook, By Food Safety (2015-2023) (US $MN)
Table 131 South America Aptamers Market Outlook, By Biosensors (2015-2023) (US $MN)
Table 132 South America Aptamers Market Outlook, By End User (2015-2023) (US $MN)
Table 133 South America Aptamers Market Outlook, By Contract Research Organizations (2015-2023) (US $MN)
Table 134 South America Aptamers Market Outlook, By Academic and Government Research Institutes (2015-2023) (US $MN)
Table 135 South America Aptamers Market Outlook, By Biotechnology and Pharmaceutical Companies (2015-2023) (US $MN)
Table 136 South America Aptamers Market Outlook, By Other End Users (2015-2023) (US $MN)
Table 137 South America Aptamers Market Outlook, By Aptamers Type (2015-2023) (US $MN)
Table 138 South America Aptamers Market Outlook, By Peptide Aptamers (2015-2023) (US $MN)
Table 139 South America Aptamers Market Outlook, By Nucleic Acid Aptamers (2015-2023) (US $MN)
Table 140 South America Aptamers Market Outlook, By RNA-Based Aptamers (2015-2023) (US $MN)
Table 141 South America Aptamers Market Outlook, By XNA-Based Aptamers (2015-2023) (US $MN)
Table 142 South America Aptamers Market Outlook, By DNA-Based Aptamers (2015-2023) (US $MN)
Table 143 South America Aptamers Market Outlook, By Technology (2015-2023) (US $MN)
Table 144 South America Aptamers Market Outlook, By SELEX (2015-2023) (US $MN)
Table 145 South America Aptamers Market Outlook, By Other Technologies (2015-2023) (US $MN)
Table 146 Middle East & Africa Aptamers Market Outlook, By Country (2015-2023) (US $MN)
Table 147 Middle East & Africa Aptamers Market Outlook, By Application (2015-2023) (US $MN)
Table 148 Middle East & Africa Aptamers Market Outlook, By Research and Development (2015-2023) (US $MN)
Table 149 Middle East & Africa Aptamers Market Outlook, By Targeted Drug Delivery (2015-2023) (US $MN)
Table 150 Middle East & Africa Aptamers Market Outlook, By Drug Discovery and Development (2015-2023) (US $MN)
Table 151 Middle East & Africa Aptamers Market Outlook, By Forensics (2015-2023) (US $MN)
Table 152 Middle East & Africa Aptamers Market Outlook, By Cancer (2015-2023) (US $MN)
Table 153 Middle East & Africa Aptamers Market Outlook, By Diagnostics (2015-2023) (US $MN)
Table 154 Middle East & Africa Aptamers Market Outlook, By Molecular Imaging (2015-2023) (US $MN)
Table 155 Middle East & Africa Aptamers Market Outlook, By Biomarker Detection and Discovery (2015-2023) (US $MN)
Table 156 Middle East & Africa Aptamers Market Outlook, By Therapeutics Development (2015-2023) (US $MN)
Table 157 Middle East & Africa Aptamers Market Outlook, By Biodefense (2015-2023) (US $MN)
Table 158 Middle East & Africa Aptamers Market Outlook, By Other Applications (2015-2023) (US $MN)
Table 159 Middle East & Africa Aptamers Market Outlook, By Food Safety (2015-2023) (US $MN)
Table 160 Middle East & Africa Aptamers Market Outlook, By Biosensors (2015-2023) (US $MN)
Table 161 Middle East & Africa Aptamers Market Outlook, By End User (2015-2023) (US $MN)
Table 162 Middle East & Africa Aptamers Market Outlook, By Contract Research Organizations (2015-2023) (US $MN)
Table 163 Middle East & Africa Aptamers Market Outlook, By Academic and Government Research Institutes (2015-2023) (US $MN)
Table 164 Middle East & Africa Aptamers Market Outlook, By Biotechnology and Pharmaceutical Companies (2015-2023) (US $MN)
Table 165 Middle East & Africa Aptamers Market Outlook, By Other End Users (2015-2023) (US $MN)
Table 166 Middle East & Africa Aptamers Market Outlook, By Aptamers Type (2015-2023) (US $MN)
Table 167 Middle East & Africa Aptamers Market Outlook, By Peptide Aptamers (2015-2023) (US $MN)
Table 168 Middle East & Africa Aptamers Market Outlook, By Nucleic Acid Aptamers (2015-2023) (US $MN)
Table 169 Middle East & Africa Aptamers Market Outlook, By RNA-Based Aptamers (2015-2023) (US $MN)
Table 170 Middle East & Africa Aptamers Market Outlook, By XNA-Based Aptamers (2015-2023) (US $MN)
Table 171 Middle East & Africa Aptamers Market Outlook, By DNA-Based Aptamers (2015-2023) (US $MN)
Table 172 Middle East & Africa Aptamers Market Outlook, By Technology (2015-2023) (US $MN)
Table 173 Middle East & Africa Aptamers Market Outlook, By SELEX (2015-2023) (US $MN)
Table 174 Middle East & Africa Aptamers Market Outlook, By Other Technologies (2015-2023) (US $MN)
